Main menu
Common skin conditions
NEWS
Join DermNet PRO
Read more
Quick links
Last reviewed: December 2023
Author(s): Dr Libby Whittaker, DermNet Medical Writer (2023)
Previous contributors: Vanessa Ngan, Staff Writer (2002)
Reviewing dermatologist: Dr Ian Coulson
Edited by the DermNet content department
Introduction
How it works
Uses
How to use
Precautions
Side effects
Capsaicin is a topical analgesic used for symptom relief in osteoarthritis and some neuralgic conditions such as post-herpetic neuralgia.
It is available as a topical cream or patch, depending on location.
Capsaicin is approved for relief of pain associated with osteoarthritis.
It has also been used for symptom relief for a variety of conditions that cause localised neuropathic pain. Uses include the following (some of which is off-label):
Capsaicin is the purified extracted alkaloid from red chilli peppers (capsicums). This is the substance that makes chilli peppers hot.
Capsaicin is thought to bind to nociceptors in the skin where it is applied, causing proinflammatory neuropeptides (eg, substance P) to be released. This leads to initial enhanced sensitivity, often felt as burning or itching, but over time depletion of substance P and nociceptor desensitisation is proposed to lead to a reduction in pain.
Capsaicin has been found to provide some degree of relief in various neuropathic pain conditions.
A Cochrane review found that ≥6 weeks of treatment with 0.075% capsaicin cream was associated with:
High concentration capsaicin patches (8%) have been associated with more patients experiencing moderate or substantial pain relief in post-herpetic neuralgia: number needed to treat (to benefit 1 patient over low concentration capsaicin) approx. 7–9 (at 8–12 weeks). Requiring a single patch application per 3 months rather than regular use of cream can also help with non-adherence.
The most common side effect of capsaicin use (approx. 50%) is a mild to moderate stinging or burning sensation after application. This sensation is related to the action of capsaicin on the skin and is to be expected. It usually diminishes after the first few days of application and in most cases will disappear with time and continued use.
Cases of irritant or allergic contact dermatitis have been reported, and rare cases of burns.
Approved datasheets are the official source of information for medicines, including approved uses, doses, and safety information. Check the individual datasheet in your country for information about medicines.
We suggest you refer to your national drug approval agency such as the Australian Therapeutic Goods Administration (TGA), US Food and Drug Administration (FDA), UK Medicines and Healthcare products regulatory agency (MHRA) / emc, and NZ Medsafe, or a national or state-approved formulary eg, the New Zealand Formulary (NZF) and New Zealand Formulary for Children (NZFC) and the British National Formulary (BNF) and British National Formulary for Children (BNFC).